Skip to content

Study on the effect of Ziyin prescription on repeated implantation failure

Clinical efficacy and mechanism of Ziyin prescription in treating repeated implantation failure in thin endometrium by regulating endometrial receptivity through TGF-ß1/E-Cadherin

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001694
Enrollment
Unknown
Registered
2025-09-09
Start date
2024-01-07
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Repeated implant failure

Interventions

ziyin group:ziyin prescription
western medicine group:vitamin E
ziyin and western medicine group:Zi-yin prescription +vitamin E

Sponsors

The Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1)Those who meet the TCM and Western medicine diagnostic criteria for infertility RIF and thin endometrium and plan to undergo IVF-ET again. 2) Aged 25 to35 years old. 3) Ultrasound examination shows that the uterine morphology is basically normal there is no abnormal echo in the uterine cavity and there is no ovarian cyst; in the previous IVF-ET cycle the thickness of the thickest part of the endometrium measured by vaginal B-ultrasound is =7mm on the day of human chorionic gonadotropin (HCG) or endometrial transformation. 4) There are frozen embryos on the third day after egg retrieval. 5) Willing to accept the treatment measures of this study can be observed for 2 menstrual cycles continuously and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1)Positive screening results for TORCH hepatitis B hepatitis C human immunodeficiency virus (HIV) and syphilis serology and infection with gonorrhea chlamydia mycoplasma etc.; 2) Combined with progressive serious primary or secondary diseases in internal medicine or surgery mental illness and chromosomal abnormalities; 3) Previous history of adverse pregnancy and delivery immune system diseases or severe wasting diseases; 4) Intrauterine adhesions submucosal uterine fibroids endometrial polyps and other intrauterine space-occupying lesions uterine malformations etc.history of abnormal embryo implantation failure

Design outcomes

Primary

MeasureTime frame
implantation rate;clinical pregnancy rate;live birth rate;early abortion rate;

Secondary

MeasureTime frame
TCM syndrome efficacy;E-Cadherin Expression in the Endometrium;HOXA10 Expression in the Endometrium;Endometrial Receptivity;TGF-ß1 Expression in the Endometrium;

Countries

china

Contacts

Public ContactZuo Wenting

Jiangsu Provincial Hospital of Traditional Chinese Medicine

875317115@qq.com15850532528

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026